Assessing the Annual Economic Burden of Preventing and Treating Anogenital Human Papillomavirus-Related Disease in the US: Analytic Framework and Review of the Literature

Author： Insinga Ralph P.   Dasbach Erik J.   Elbasha Elamin H.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.11, 2005-01, pp. : 1107-1122

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Economic Burden of Multiple Sclerosis: A Systematic Review of the Literature

By Naci Huseyin  

PharmacoEconomics, Vol. 28, Iss. 5, 2010-05 ,pp. : 363-379

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic Considerations in Treating Iron Overload in Patients with β-Thalassaemia, Sickle Cell Disease and Myelodysplastic Syndromes in the US: A Literature Review

By Zhang Bin  

PharmacoEconomics, Vol. 29, Iss. 6, 2011-06 ,pp. : 461-474

Adis International

Access to resources Recommend Favorite

Economic burden of osteoarthritis in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 596, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Economic burden of psoriasis in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Topical treatment of anogenital human papillomavirus infection in male patients

By Ankerst Donna P   Diepolder Helmut   Horster Sophia  

Future Virology, Vol. 4, Iss. 6, 2009-11 ,pp. : 531-541

Future Medicine

Access to resources Recommend Favorite